MHRA Drug Safety Update – March 2018

MHRA Drug Safety Update – March 2018

March 12, 2018

Date Issued: 8th March 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 8, March 2018) has been published and includes articles on:

  • daclizumab (Zinbryta▼): suspension and recall for safety reasons; review patients as soon as possible and start alternative therapy;
  • Esmya (ulipristal acetate) for uterine fibroids: do not initiate or re-start treatment; monitor liver function in current and recent users; and
  • head lice eradication products: risk of serious burns if treated hair is exposed to open flames or other sources of ignition, for example, cigarettes.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...